Evaluation of the metabolic and vascular effects of a nutritional mixture of Berberine – Citrus – Apple extracts in a rat model of experimental metabolic syndrome

2021 ◽  
Author(s):  
M Siliman Misha ◽  
J.-C. Desfontis ◽  
K Ouguerram ◽  
M.Y Mallem
PPAR Research ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-9 ◽  
Author(s):  
Zhigang Zhao ◽  
Zhidan Luo ◽  
Peijian Wang ◽  
Jing Sun ◽  
Hao Yu ◽  
...  

Vascular endothelial dysfunction has been demonstrated in metabolic syndrome (MS). Chronic administration of rosiglitazone ameliorates endothelial dysfunction through PPARγ-mediated metabolic improvements. Recently, studies suggested that single dose of rosiglitazone also has direct vascular effects, but the mechanisms remain uncertain. Here we established a diet-induced rat model of MS. The impaired vasorelaxation in MS rats was improved by incubating arteries with rosiglitazone for one hour. Importantly, this effect was blocked by either inhibition of PPARγor PPARδ. In cultured endothelial cells, acute treatment with rosiglitazone increased the phosphorylation of Akt and eNOS and the production of NO. These effects were also abolished by inhibition of PPARγ, PPARδ, or PI3K. In conclusion, rosiglitazone improved endothelial function through both PPARγ- and PPARδ-mediated phosphorylation of Akt and eNOS, which might help to reconsider the complex effects and clinical applications of rosiglitazone.


Obesity ◽  
2008 ◽  
Vol 16 (10) ◽  
pp. 2253-2258 ◽  
Author(s):  
Mahmood S. Mozaffari ◽  
Stephen W. Schaffer

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i110-i110
Author(s):  
Yutaka Kakizoe ◽  
Teruhiko Mizumoto ◽  
Terumasa Nakagawa ◽  
Manabu Hayata ◽  
Yuichiro Izumi ◽  
...  

2010 ◽  
Vol 161 (2) ◽  
pp. 350-364 ◽  
Author(s):  
Cristina Contreras ◽  
Ana Sánchez ◽  
Pilar Martínez ◽  
Rafaela Raposo ◽  
Belén Climent ◽  
...  

Author(s):  
Nehal S. Wahba ◽  
Rasha H. Abdel‐Ghany ◽  
Salah A. Ghareib ◽  
Mohamed Abdel‐Aal ◽  
Amira E. Alsemeh ◽  
...  

2013 ◽  
Vol 27 (S1) ◽  
Author(s):  
David M Eaton ◽  
Ashley N Rogers ◽  
Ami E Rice ◽  
Kathy Coy ◽  
Richard G Peterson ◽  
...  
Keyword(s):  

F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 1013
Author(s):  
Mifetika Lukitasari ◽  
Mohammad Saifur Rohman ◽  
Dwi Adi Nugroho ◽  
Nila Aisyah Wahyuni ◽  
Mukhamad Nur Kholis ◽  
...  

Background: Metabolic syndrome is a significant risk factor for cardiovascular diseases. Green tea and green coffee extracts, antioxidant and anti-inflammatory agents may participate in metabolic syndrome-induced cardiac fibrosis alleviation. However, the effect of combination of those extracts still needs exploration. Therefore, this study investigated the effect of green tea and decaffeinated light roasted green coffee extracts and their combination in metabolic syndrome-induced cardiac fibrosis rats. Methods: Metabolic syndrome rat model was i1nduced through high-fat high sucrose diets feeding for 8 weeks and injection of low dose streptozotocin at the 2nd week. The metabolic syndrome rats were divided into 4 experimental groups metabolic syndrome rats (MS); metabolic syndrome rats treated with 300 mg/ kg b.w green tea extract (GT); metabolic syndrome rats treated with 200 mg/ kg b.w decaffeinated light roasted green coffee extract (GC); metabolic syndrome rats treated with the combination of the two extracts (CE); and a normal control (NC) group was added. Angiotensin 2 level was analyzed by ELISA method. Gene expression of NF-κB, TNF-α, IL-6, Tgf-β1, Rac-1, and α-sma were analyzed by touchdown polymerase chain reaction methods. Results: Metabolic syndrome rats treated with green tea and decaffeinated light roasted green coffee significantly decreased angiotensin-2 serum level and cardiac inflammation and fibrosis gene expression level (NF-κB, TNF-α, IL-6, Tgf-β1, Rac-1, and α-sma). More significant alleviation was observed in the combination group. Conclusion: This study suggested that combination of green tea and decaffeinated light roasted green coffee extracts showed better improvement in metabolic syndrome-induced cardiac fibrosis rat model compared to that of single extract administration through inflammation inhibition


2012 ◽  
Vol 26 (S1) ◽  
Author(s):  
Paul Ernsberger ◽  
Akshita Agarwal ◽  
Beth Lute ◽  
Richard J Koletsky
Keyword(s):  

2010 ◽  
Vol 24 (S1) ◽  
Author(s):  
C Subah Packer ◽  
Leeanna M Meulen ◽  
Alexa M Boice ◽  
Kathy Coy ◽  
Richard G Peterson

Sign in / Sign up

Export Citation Format

Share Document